<DOC>
	<DOCNO>NCT01411930</DOCNO>
	<brief_summary>Antipsychotic medicine use treat mental illness associate effect blood sugar control . Laboratory study show certain medication particular may alter insulin work . One purpose study determine antipsychotic medication immediate effect insulin action individual mental disorder , risk factor diabetes . A second purpose demonstrate feasibility use volunteer without psychiatric disorder , take psychiatric medication , mean study antipsychotic metabolic effect .</brief_summary>
	<brief_title>Acute Impact Intramuscular ( IM ) Aripiprazole Olanzapine Insulin Resistance High Risk Prediabetics</brief_title>
	<detailed_description>Antipsychotic medication treat severe psychiatric symptom , hallucination , paranoid thought , delusion . Research show medication may put people high risk metabolic derangement , insulin resistance . Certain antipsychotic , like clozapine olanzapine , associate high risk metabolic side effect others , like aripiprazole ziprasidone . This study compare effect single dos two antipsychotic medication , olanzapine aripiprazole , insulin action nonpsychiatrically ill volunteer subject . Participation study last 6 week . Participants first complete screen visit include follow : oral glucose tolerance test ( OGTT ) , involve blood draw , consumption sugar drink , second blood draw ; review medical psychiatric history , include use medicine psychiatric medication ; measurement participant ' height weight . The second visit , schedule 2 week screen , include tracer-clamp study test participant ' body handle sugar . The tracer-clamp study conduct course one night morning require participant stay study location overnight . At 3 AM , participant receive intravenous line ( IV ) sugar solution . Just 8 AM , receive second IV opposite arm draw blood monitor blood sugar level . At 8 AM , participant begin receive insulin first IV ; blood sample draw blood sugar level monitor time ensure remain within healthy range . At 11 AM , participant receive injection antipsychotic medication arm muscle . The antipsychotic , randomly assign , either olanzapine aripiprazole . Participants monitor 3 hour receive injection antipsychotic medication ; time , blood sample draw , blood sugar level monitor ensure within healthy range , secondary medication available counteract certain side effect antipsychotic . After 4 week , participant undergo 2nd tracer-clamp study , time receive antipsychotic give first clamp study . The protocol visit otherwise identical first clamp study .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>No history axis I mood , anxiety psychotic disorder ( confirm Structured Clinical Interview DSMIV ) , take psychotropics Prediabetic , base finding impaired glucose tolerance ( 2 hour postload serum glucose 140199 mg/dl ) 75 gram standard oral glucose tolerance test within past 90 day Family history type 2 diabetes mellitus BMI 2535 kg/m2 Males , age 4065 inclusive English speaker ability provide inform consent Nonsmoker History Axis I Mood , Anxiety Psychotic Disorder Use Psychotropics</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>